USP delays official effective dates of new and revised compounding standards

Sep 23, 2019 - 03:14 PM
compliance-deadline

The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.

Related News Articles

Headline
Infant formula recall expands as botulism outbreak cases grow
ByHeart has expanded its voluntary recall to include all Whole Nutrition Infant Formula cans and Anywhere Pack products amid an investigation by the Food and…
Headline
Study finds 5,000 steps per day could slow cognitive decline for individuals with signs of Alzheimer’s
A study published today by Nature found that as many as 5,000 steps per day can slow cognitive decline for individuals with early signs of Alzheimer’s disease…
Headline
Blog shares insights from hospital leaders at AHA’s inaugural Rural Patient Safety Convening
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Headline
FDA sends warning letter to Philips due to quality issues 
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…
Blog
Smarter, Safer Hospitals: How HCA Healthcare Is Using AI to Redefine Patient Safety
Public
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
Most serious FDA recall issued for Abiomed heart pump controllers
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…